Discover
BGLC
BioNexus Gene Lab Corp.
1.29
2 x 1.01
2 x 1.65
bid
ask
-
0.04
2.70%
2 @ 04:00 PM
1.30 +0.01 (0.78%)
| Ytd | -67.34% | |
| 1y | -76.02% |
1.21
day range
1.29
1.20
52 week range
5.48
| Open | 1.21 | Prev Close | 1.33 | Low | 1.21 | High | 1.29 | Mkt Cap | 3.78M |
| Vol | 3.88K | Avg Vol | 11.02K | EPS | -1.26 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.87 | Short Ratio | 2.21 | Inst. Own | 0.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.46 | 200-d Avg | 2.18 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 416.38K | ||
| Research and Development Expense | 13.67K | ||
| Selling, General and Administrative Expense | 334.55K | ||
| Operating Income | -416.38K | ||
| Interest Expense | 4.06K | ||
| Net Income | -286.45K | ||
| Net Income Common Stock | -286.45K | ||
| Net Income Common Stock (USD) | -286.45K | ||
| Consolidated Income | -286.45K | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -282.40K | ||
| Earning Before Interest & Taxes (USD) | -282.40K | ||
| Weighted Average Shares | 2.42M | ||
| Weighted Average Shares Diluted | 2.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.23M | ||
| Cash and Equivalents (USD) | 1.23M | ||
| Investments | 4.32M | ||
| Investments Current | 2.29M | ||
| Investments Non-Current | 2.03M | ||
| Trade and Non-Trade Receivables | 124.52K | ||
| Current Assets | 4.94M | ||
| Property, Plant & Equipment Net | 1.76M | ||
| Total Assets | 8.73M | ||
| Debt Current | 188.15K | ||
| Total Debt | 323.20K | ||
| Current Liabilities | 812.94K | ||
| Debt Non-Current | 135.04K | ||
| Total Liabilities | 947.98K | ||
| Accumulated Retained Earnings (Deficit) | -7.26M | ||
| Accumulated Other Comprehensive Income | -127.21K | ||
| Shareholders Equity | 7.78M | ||
| Shareholders Equity (USD) | 7.78M | ||
| Assets Non-Current | 3.78M | ||
| Total Debt (USD) | 323.20K | ||
| Deferred Revenue | 8.35K | ||
| Inventory | 652.89K | ||
| Liabilities Non-Current | 135.04K | ||
| Trade and Non-Trade Payables | 7.90K | ||
| Tax Assets | 61.14K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 46.39K | ||
| Net Cash Flow from Financing | 13.61K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.03K | ||
| Capital Expenditure | -21.26K | ||
| Issuance (Repayment) of Debt Securities | 13.61K | ||
| Net Cash Flow from Investing | 416.14K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 437.40K | ||
| Net Cash Flow from Operations | -422.49K | ||
| Effect of Exchange Rate Changes on Cash | -13.29K | ||